Merit Medical Systems, Inc. (NASDAQ:MMSI – Get Rating) – Analysts at Oppenheimer reduced their Q2 2022 EPS estimates for shares of Merit Medical Systems in a research note issued to investors on Thursday, April 28th. Oppenheimer analyst S. Lichtman now anticipates that the medical instruments supplier will earn $0.57 per share for the quarter, down from their prior forecast of $0.67. Oppenheimer also issued estimates for Merit Medical Systems’ Q3 2022 earnings at $0.66 EPS.
Merit Medical Systems (NASDAQ:MMSI – Get Rating) last issued its earnings results on Wednesday, April 27th. The medical instruments supplier reported $0.53 earnings per share for the quarter, topping analysts’ consensus estimates of $0.47 by $0.06. Merit Medical Systems had a net margin of 4.36% and a return on equity of 13.47%. During the same quarter last year, the firm earned $0.52 earnings per share.
Shares of NASDAQ:MMSI opened at $62.01 on Monday. The company has a quick ratio of 1.10, a current ratio of 2.04 and a debt-to-equity ratio of 0.23. The firm has a market capitalization of $3.51 billion, a PE ratio of 73.82, a P/E/G ratio of 2.43 and a beta of 1.03. Merit Medical Systems has a twelve month low of $51.66 and a twelve month high of $73.85. The company has a 50-day moving average price of $64.89 and a two-hundred day moving average price of $63.47.
A number of large investors have recently modified their holdings of the stock. Emerald Advisers LLC raised its position in Merit Medical Systems by 10.3% in the 1st quarter. Emerald Advisers LLC now owns 558,371 shares of the medical instruments supplier’s stock worth $37,143,000 after purchasing an additional 52,020 shares during the period. Nisa Investment Advisors LLC grew its holdings in Merit Medical Systems by 27.7% in the 1st quarter. Nisa Investment Advisors LLC now owns 3,690 shares of the medical instruments supplier’s stock worth $245,000 after acquiring an additional 800 shares during the last quarter. Hardy Reed LLC bought a new stake in Merit Medical Systems in the 1st quarter worth $155,000. Comerica Bank grew its holdings in Merit Medical Systems by 1.1% in the 1st quarter. Comerica Bank now owns 248,484 shares of the medical instruments supplier’s stock worth $17,516,000 after acquiring an additional 2,594 shares during the last quarter. Finally, AMI Asset Management Corp grew its holdings in Merit Medical Systems by 5.7% in the 1st quarter. AMI Asset Management Corp now owns 142,912 shares of the medical instruments supplier’s stock worth $9,507,000 after acquiring an additional 7,763 shares during the last quarter. Institutional investors own 95.93% of the company’s stock.
About Merit Medical Systems (Get Rating)
Merit Medical Systems, Inc designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy.
- Get a free copy of the StockNews.com research report on Merit Medical Systems (MMSI)
- Why is Chevron Stock Falling After Strong Earnings?
- MarketBeat: Week in Review 4/25 – 4/29
- Apple’s Numbers Complete Trifecta
- Rogers Communication Stock Should Be Launching Higher
- Iridium Communications Stock is Ready to Return to Orbit
Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.